Buffered Form of Sevelamer Carbonate Exhibits Promise

Susan Farley
Published Online: Sunday, July 1, 2007

Genzyme's sevelamer carbonate (Renvela) successfully and significantly reduced serum phosphorus for hyperphosphalemic patients who have chronic kidney disease but are not on dialysis. This was the primary end point for the study, which also showed that sevelamer carbonate significantly reduced calcium phosphorus product and low-density lipoprotein cholesterol. Sevelamer carbonate was welltolerated and exhibited a safety profile similar to sevelamer hydrochloride (Renagel). The multicenter, open-label study included 49 patients in Europe and Australia. In the United States, sevelamer hydrochloride is the most prescribed phosphate binder; sevelamer carbonate is a buffered form of sevelamer hydrochloride that is calcium-free and metal-free. Once FDA-approved, sevelamer carbonate will be available in 800-mg tablets.



Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues
$auto_registration$
VSEO N/A